ICU Medical (NASDAQ: ICUI) reported Q3 EPS of $1.59, $0.34 better than the analyst estimate of $1.25. Revenue for the quarter came in at $589.1 million versus the consensus estimate of $574.6 million.

GUIDANCE:

ICU Medical sees FY2024 EPS of $5.40-$5.70, versus the consensus of $5.22.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.